시장보고서

상품코드

1464683

신경줄기세포 시장 : 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Neural Stem Cells Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 04월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 278 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

신경줄기세포 시장 규모는 2023년에 67억 5,600만 달러에 달하며, 2024-2032년 CAGR 12.5%로 확대

신경줄기세포 시장 - 시장 역학

신경질환에 대한 의식의 향상이 시장 수요를 촉진할 전망

신경질환에 대한 인식이 높아짐에 따라 신경질환에 대한 인식과 진단이 향상되고 있습니다. 그 결과, 조기 진단이 가능해져 치료에 대한 적극적인 접근이 가능해졌으며, NSC를 포함한 재생 치료는 현재 치료 옵션의 일부로 고려되고 있습니다. 유엔의 최근 보고서에 따르면 알츠하이머병, 파킨슨병, 뇌졸중, 다발성 경화증, 간질, 편두통, 뇌 손상, 신경 감염 등 다양한 신경 질환을 앓고 있는 사람이 6명 중 1명, 총 10억 명에 달한다고 합니다. 안타깝게도 이러한 질병으로 인해 매년 약 680만 명이 사망하고 있으며, CRISPR-Cas9와 같은 생명공학 및 유전자 편집 기술은 NSCs의 치료 가능성을 높일 수 있는 유망한 기회를 제공합니다. 그러나 시장 성장은 제조상의 문제로 인해 제한될 수 있습니다.

신경줄기세포 시장 - 주요 인사이트

당사의 리서치 분석가들의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 12.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

시장별로는 병원이 2023년 가장 큰 시장 점유율을 보일 것으로 예상됩니다.

지역별로는 북미가 2023년 매출 1위를 차지했습니다.

신경줄기세포 시장 - 세분화 분석 :

세계 신경 줄기세포 시장은 유형, 애플리케이션 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 신경관 상피세포, 신경교세포, 신경아세포, 신경전구세포의 세 가지 그룹으로 분류됩니다. 신경줄기세포 시장은 신경과학 연구, 재생의학 및 치료법 개발에 응용될 수 있는 뚜렷한 특성을 가진 다양한 유형의 세포로 구성됩니다.

시장은 용도에 따라 의료, 병원, 연구실 등 세 가지 범주로 나뉩니다. 이 시장에서는 줄기세포 임상시험에 참여하는 환자를 포함한 신경 질환 및 부상 환자를 대상으로 광범위한 치료 및 재활 서비스를 제공하는 병원 카테고리가 압도적인 점유율을 차지하고 있습니다.

신경줄기세포 시장 - 지역적 인사이트

신경줄기세포 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 걸쳐 지역적으로 분포되어 있습니다. 이 지역들은 사업 활동을 하는 국가를 기준으로 세분화됩니다. 북미가 시장을 독점하고 있는 것은 주로 첨단화된 의료 인프라에 기인합니다. 이 지역의 강력한 의료 인프라는 줄기세포 생물학 및 재생의학 분야의 광범위한 연구개발을 지원하고 있으며, 2022년 말까지 미국은 세계에서 가장 많은 의료비를 지출하는 국가로 4조 5,000억 달러를 지출할 것으로 예상됩니다. 의료비 지출은 4조 3,000억 달러로 GDP의 18.5%를 차지할 것으로 추정됩니다. 유럽은 시장 성장에서 두 번째로 큰 지역을 차지하고 있는데, 이는 주로 연구개발에 대한 적극적인 노력에 기인합니다.

신경줄기세포 시장 - 경쟁상황:

신경줄기세포 시장은 재생의료에 대한 관심 증가와 다양한 신경질환 치료에 있으며, 줄기세포 치료의 유망한 가능성으로 인해 경쟁이 치열한 시장으로 부상하고 있습니다. 수많은 기업과 연구기관들이 신경줄기세포를 이용한 제품 및 치료법 개발 및 상용화에 적극 나서고 있습니다. 이들 기업은 제품 혁신, 연구개발, 전략적 파트너십, 시장 확대 노력을 통해 신경줄기세포 시장에서 경쟁 우위를 확보하기 위해 노력하고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제10장 주요 벤더 분석 - 신경줄기세포 업계

경쟁 대시보드
기업 개요
- Cellular Dynamics International
- Stemedica Cell Technologies Inc
- Fibrocell Science Inc
- Corestem Inc, Corning Inc.
- Celgene Corporation
- Kangstem Biotech Ltd
- Ge Healthcare
- Biotime Inc
- Thermo Fisher Vericel Corporation
- Cellular Engineering Technologies Inc
- Brainstorm Cell Therapeutics
- Cytori Therapeutics
- Becton Dickinson
- Takara Holdings Inc.
- Others

제11장 애널리스트의 전방위 전망

KSA 24.05.23

REPORT HIGHLIGHT

Neural Stem Cells Market size was valued at USD 6,756 Million in 2023, expanding at a CAGR of 12.5% from 2024 to 2032.

Neural stem cells are undifferentiated cells found in the central nervous system. These cells can produce new cells that can mature into neurons and glial cells. Ongoing research on neural stem cells aims to explore their potential in regenerative medicine and neuroscience, with a focus on understanding their characteristics, controlling their functions, and creating reliable treatments for neurological conditions.

Neural Stem Cells Market- Market Dynamics

Increasing awareness about neurological disease is expected to propel market demand

The recognition and diagnosis of neurological diseases have improved as awareness about these conditions increases. This has led to early diagnosis, which often results in a proactive approach to treatment. Regenerative therapies involving NSCs are now being considered as part of the treatment options. According to a recent United Nations report, approximately one in six people, totaling up to 1 billion individuals, suffer from various neurological disorders, including Alzheimer's disease, Parkinson's disease, strokes, multiple sclerosis, epilepsy, migraines, brain injuries, and neuro-infections. Sadly, around 6.8 million people die each year due to these conditions. Biotechnology and gene editing techniques, such as CRISPR-Cas9, present promising opportunities for enhancing the therapeutic potential of NSCs. However, the growth of the market may be limited by manufacturing challenges.

Neural Stem Cells Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.5% over the forecast period (2024-2032)

Based on Application segmentation, Hospital was predicted to show maximum market share in the year 2023

Based on region, North America was the leading revenue generator in 2023

Neural Stem Cells Market- Segmentation Analysis:

The Global Neural Stem Cells Market is segmented based on Type, Application, and Region.

The market is categorized into three groups according to Type: Neural tube epithelial cells, Neuroglial cells, Neuroblast, and Neural precursor cells. The Neural Stem Cells market comprises a wide range of cell types that possess distinct properties and find applications in neuroscience research, regenerative medicine, and therapeutic development.

The market is segmented into three categories according to their application: Medical care, Hospital, and Laboratory. The dominant sector in the market is the Hospital category, which offers extensive care and rehabilitation services to patients with neurological disorders and injuries, including those involved in stem cell clinical trials.

Neural Stem Cells Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The North American region dominates the market, primarily due to its advanced healthcare infrastructure. The strong healthcare infrastructure in this region supports extensive research and development in the field of stem cell biology and regenerative medicine. By the end of 2022, the United States is projected to spend USD 4.5 trillion on healthcare, making it the country with the highest overall healthcare spending in the world. In 2021, the United States' healthcare spending is estimated to be USD 4.3 trillion, accounting for 18.5% of its GDP. Europe holds the second-largest region for market growth, mainly attributed to its robust research and development efforts.

Neural Stem Cells Market- Competitive Landscape:

The market for neural stem cells is highly competitive due to the increasing focus on regenerative medicine and the promising potential of stem cell therapies in treating different neurological disorders. Numerous companies and research institutions are actively engaged in the advancement and commercialization of products and therapies based on neural stem cells. These companies are striving to gain a competitive advantage in the neural stem cells market through product innovation, research and development, strategic partnerships, and market expansion efforts.

Recent Developments:

In January 2023, Stemedica Cell Technologies has revealed the initiation of a phase 2b/3 clinical trial aimed at evaluating the safety, effectiveness, and tolerance of a sole IV injection of allogeneic mesenchymal stem cells in individuals suffering from chronic ischemic stroke.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEURAL STEM CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Cellular Dynamics International

Stemedica Cell Technologies Inc

Fibrocell Science Inc

Corestem Inc, Corning Inc.

Celgene Corporation

Kangstem Biotech Ltd

Ge Healthcare

Biotime Inc

Thermo Fisher Vericel Corporation

Cellular Engineering Technologies Inc

Brainstorm Cell Therapeutics

Cytori Therapeutics

Becton Dickinson

Takara Holdings Inc.

Others

GLOBAL NEURAL STEM CELLS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Neural tube epithelial cells
Neuroglial cell
Neuroblast
Neural precursor cell

GLOBAL NEURAL STEM CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Medical care
Hospital
Laboratory

GLOBAL NEURAL STEM CELLS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Neural Stem Cells Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Neural Stem Cells Market Snippet by Product Type
- 2.1.2.Neural Stem Cells Market Snippet by Application
- 2.1.3.Neural Stem Cells Market Snippet by Country
- 2.1.4.Neural Stem Cells Market Snippet by Region
2.2.Competitive Insights

3.Neural Stem Cells Key Market Trends

3.1.Neural Stem Cells Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Neural Stem Cells Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Neural Stem Cells Market Opportunities
3.4.Neural Stem Cells Market Future Trends

4.Neural Stem Cells Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Neural Stem Cells Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Neural Stem Cells Market Landscape

6.1.Neural Stem Cells Market Share Analysis, 2022
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Neural Stem Cells Market - By Product Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Product Type, 2022 & 2030 (%)
- 7.1.2.Neural tube epithelial cells
- 7.1.3.Neuroglial cell
- 7.1.4.Neuroblast
- 7.1.5.Neural precursor cell

8.Neural Stem Cells Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2.Medical care
- 8.1.3.Hospital
- 8.1.4.Laboratory

9.Neural Stem Cells Market- By Geography

9.1.Introduction
- 9.1.1.Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2.North America
- 9.2.1.Overview
- 9.2.2.Neural Stem Cells Key Manufacturers in North America
- 9.2.3.North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4.North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.5.North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6.U.S.
  - 9.2.6.1.Overview
  - 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.2.6.4.U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.7.Canada
  - 9.2.7.1.Overview
  - 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.2.7.4.Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.Europe
- 9.3.1.Overview
- 9.3.2.Neural Stem Cells Key Manufacturers in Europe
- 9.3.3.Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4.Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.5.Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.6.Germany
  - 9.3.6.1.Overview
  - 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.6.4.Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.7.Italy
  - 9.3.7.1.Overview
  - 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.7.4.Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.8.United Kingdom
  - 9.3.8.1.Overview
  - 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.9.France
  - 9.3.9.1.Overview
  - 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.9.3.France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.9.4.France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.10.Russia
  - 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.10.3.Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.11.Netherlands
  - 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.12.Sweden
  - 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.12.3.Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.13.Poland
  - 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.13.3.Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.14.Rest of Europe
  - 9.3.14.1.Overview
  - 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.Asia Pacific (APAC)
- 9.4.1.Overview
- 9.4.2.Neural Stem Cells Key Manufacturers in Asia Pacific
- 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.6.India
  - 9.4.6.1.Overview
  - 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.6.3.India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.6.4.India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.7.China
  - 9.4.7.1.Overview
  - 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.7.3.China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.7.4.China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.8.Japan
  - 9.4.8.1.Overview
  - 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.8.4.Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.9.South Korea
  - 9.4.9.1.Overview
  - 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.9.4.South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.10.Australia
  - 9.4.10.1.Overview
  - 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.10.4.Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.11.Thailand
  - 9.4.11.1.Overview
  - 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.11.4.Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.12.Indonesia
  - 9.4.12.1.Overview
  - 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.13.Philippines
  - 9.4.13.1.Overview
  - 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.13.4.Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.14.Rest of APAC
  - 9.4.14.1.Overview
  - 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.Latin America
- 9.5.1.Overview
- 9.5.2.Neural Stem Cells Key Manufacturers in Latin America
- 9.5.3.Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4.Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.5.Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.6.Brazil
  - 9.5.6.1.Overview
  - 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.6.4.Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.7.Mexico
  - 9.5.7.1.Overview
  - 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.7.4.Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.8.Argentina
  - 9.5.8.1.Overview
  - 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.8.4.Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.9.Colombia
  - 9.5.9.1.Overview
  - 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.9.4.Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.10.Rest of LATAM
  - 9.5.10.1.Overview
  - 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.Middle East and Africa
- 9.6.1.Overview
- 9.6.2.Neural Stem Cells Key Manufacturers in Middle East and Africa
- 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.6.Saudi Arabia
  - 9.6.6.1.Overview
  - 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.7.United Arab Emirates
  - 9.6.7.1.Overview
  - 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.8.Israel
  - 9.6.8.1.Overview
  - 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.8.4.Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.9.Turkey
  - 9.6.9.1.Overview
  - 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.9.4.Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.10.Algeria
  - 9.6.10.1.Overview
  - 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.10.4.Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.11.Egypt
  - 9.6.11.1.Overview
  - 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.11.4.Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.12.Rest of MEA
  - 9.6.12.1.Overview
  - 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10.Key Vendor Analysis- Neural Stem Cells Industry

10.1.Competitive Dashboard
10.2.Company Profiles
- 10.2.1.Cellular Dynamics International
- 10.2.2.Stemedica Cell Technologies Inc
- 10.2.3.Fibrocell Science Inc
- 10.2.4.Corestem Inc, Corning Inc.
- 10.2.5.Celgene Corporation
- 10.2.6.Kangstem Biotech Ltd
- 10.2.7.Ge Healthcare
- 10.2.8.Biotime Inc
- 10.2.9.Thermo Fisher Vericel Corporation
- 10.2.10.Cellular Engineering Technologies Inc
- 10.2.11.Brainstorm Cell Therapeutics
- 10.2.12.Cytori Therapeutics
- 10.2.13.Becton Dickinson
- 10.2.14.Takara Holdings Inc.
- 10.2.15.Others

11.360 Degree Analyst View

12.Appendix

12.1.Research Methodology
12.2.References
12.3.Abbreviations
12.4.Disclaimer
12.5.Contact Us